Triangle Insights promotes Sarah Jims to partner

Triangle Insights, a Durham, NC-based life sciences consulting firm, has promoted Sarah Jims to partner.

Based in Triangle’s headquarters, Jims has more than a decade of experience in the life sciences industry. Since joining the firm in 2014 as an associate strategy consultant, Jims has advised numerous biotech and pharma clients on commercial assessment, portfolio strategy, commercialization strategy, and launch readiness. She has particular expertise advising on cell and gene therapy.

Jims was named a manager in 2018 and a principal in 2021.

She has a PhD in pharmacology from the University of North Carolina at Chapel Hill and a bachelor’s degree in biochemistry and molecular biology from the University of Richmond.

“Sarah has made invaluable contributions to Triangle's success throughout her years at the firm," said Gautam Aggarwal, co-founder of Triangle Insights. "She has demonstrated consistent excellence in client delivery across a breadth of consulting engagements and is highly respected as a key advisor in life sciences consulting. We look forward to the key role Sarah will play in accelerating further growth of the company."

Triangle was founded in 2013 by a team of strategy consultants who formerly worked at Campbell Alliance, Mercer, Boston Consulting Group, and Boston Healthcare. The firm provides services in pricing and market access; marketing, commercialization, and sales; and corporate and business development.

Triangle has expertise across key therapeutic areas including oncology, CNS, cell, and gene therapy. The firm has 52 employees listed on LinkedIn and offices in Durham, New York City, and San Francisco.

TrialCard, a Morrisville, NC-based life sciences commercialization firm, acquired Triangle in April 2022.